These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 30252181)

  • 1. Concurrent AFG3L2 and SPG7 mutations associated with syndromic parkinsonism and optic atrophy with aberrant OPA1 processing and mitochondrial network fragmentation.
    Magri S; Fracasso V; Plumari M; Alfei E; Ghezzi D; Gellera C; Rusmini P; Poletti A; Di Bella D; Elia AE; Pantaleoni C; Taroni F
    Hum Mutat; 2018 Dec; 39(12):2060-2071. PubMed ID: 30252181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel AFG3L2 mutation close to AAA domain leads to aberrant OMA1 and OPA1 processing in a family with optic atrophy.
    Baderna V; Schultz J; Kearns LS; Fahey M; Thompson BA; Ruddle JB; Huq A; Maltecca F
    Acta Neuropathol Commun; 2020 Jun; 8(1):93. PubMed ID: 32600459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases.
    Pierson TM; Adams D; Bonn F; Martinelli P; Cherukuri PF; Teer JK; Hansen NF; Cruz P; Mullikin For The Nisc Comparative Sequencing Program JC; Blakesley RW; Golas G; Kwan J; Sandler A; Fuentes Fajardo K; Markello T; Tifft C; Blackstone C; Rugarli EI; Langer T; Gahl WA; Toro C
    PLoS Genet; 2011 Oct; 7(10):e1002325. PubMed ID: 22022284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATPase Domain AFG3L2 Mutations Alter OPA1 Processing and Cause Optic Neuropathy.
    Caporali L; Magri S; Legati A; Del Dotto V; Tagliavini F; Balistreri F; Nasca A; La Morgia C; Carbonelli M; Valentino ML; Lamantea E; Baratta S; Schöls L; Schüle R; Barboni P; Cascavilla ML; Maresca A; Capristo M; Ardissone A; Pareyson D; Cammarata G; Melzi L; Zeviani M; Peverelli L; Lamperti C; Marzoli SB; Fang M; Synofzik M; Ghezzi D; Carelli V; Taroni F
    Ann Neurol; 2020 Jul; 88(1):18-32. PubMed ID: 32219868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m-AAA proteases, mitochondrial calcium homeostasis and neurodegeneration.
    Patron M; Sprenger HG; Langer T
    Cell Res; 2018 Mar; 28(3):296-306. PubMed ID: 29451229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic variants in the AFG3L2 proteolytic domain cause SCA28 through haploinsufficiency and proteostatic stress-driven OMA1 activation.
    Tulli S; Del Bondio A; Baderna V; Mazza D; Codazzi F; Pierson TM; Ambrosi A; Nolte D; Goizet C; Toro C; Baets J; Deconinck T; DeJonghe P; Mandich P; Casari G; Maltecca F
    J Med Genet; 2019 Aug; 56(8):499-511. PubMed ID: 30910913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AFG3L2 supports mitochondrial protein synthesis and Purkinje cell survival.
    Almajan ER; Richter R; Paeger L; Martinelli P; Barth E; Decker T; Larsson NG; Kloppenburg P; Langer T; Rugarli EI
    J Clin Invest; 2012 Nov; 122(11):4048-58. PubMed ID: 23041622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Mitochondrial AAA Proteases AFG3L2 and YME1L Impairs Mitochondrial Structure and Respiratory Chain Biogenesis.
    Cesnekova J; Rodinova M; Hansikova H; Zeman J; Stiburek L
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity.
    Mancini C; Hoxha E; Iommarini L; Brussino A; Richter U; Montarolo F; Cagnoli C; Parolisi R; Gondor Morosini DI; Nicolò V; Maltecca F; Muratori L; Ronchi G; Geuna S; Arnaboldi F; Donetti E; Giorgio E; Cavalieri S; Di Gregorio E; Pozzi E; Ferrero M; Riberi E; Casari G; Altruda F; Turco E; Gasparre G; Battersby BJ; Porcelli AM; Ferrero E; Brusco A; Tempia F
    Neurobiol Dis; 2019 Apr; 124():14-28. PubMed ID: 30389403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinocerebellar Ataxia Type 28-Phenotypic and Molecular Characterization of a Family with Heterozygous and Compound-Heterozygous Mutations in AFG3L2.
    Tunc S; Dulovic-Mahlow M; Baumann H; Baaske MK; Jahn M; Junker J; Münchau A; Brüggemann N; Lohmann K
    Cerebellum; 2019 Aug; 18(4):817-822. PubMed ID: 31111429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocyte-specific deletion of the mitochondrial m-AAA protease reveals glial contribution to neurodegeneration.
    Murru S; Hess S; Barth E; Almajan ER; Schatton D; Hermans S; Brodesser S; Langer T; Kloppenburg P; Rugarli EI
    Glia; 2019 Aug; 67(8):1526-1541. PubMed ID: 30989755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spastic ataxia with eye-of-the-tiger-like sign in 4 siblings due to novel compound heterozygous AFG3L2 mutation.
    Calandra CR; Buda G; Vishnopolska SA; Oliveri J; Olivieri FA; Pérez Millán MI; Biagioli G; Miquelini LA; Pellene AL; Marti MA
    Parkinsonism Relat Disord; 2020 Apr; 73():52-54. PubMed ID: 32248051
    [No Abstract]   [Full Text] [Related]  

  • 13. Mouse brain expression patterns of Spg7, Afg3l1, and Afg3l2 transcripts, encoding for the mitochondrial m-AAA protease.
    Sacco T; Boda E; Hoxha E; Pizzo R; Cagnoli C; Brusco A; Tempia F
    BMC Neurosci; 2010 Apr; 11():55. PubMed ID: 20426821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained OMA1-mediated integrated stress response is beneficial for spastic ataxia type 5.
    Franchino CA; Brughera M; Baderna V; De Ritis D; Rocco A; Seneca S; Regal L; Podini P; D'Antonio M; Toro C; Quattrini A; Scalais E; Maltecca F
    Brain; 2024 Mar; 147(3):1043-1056. PubMed ID: 37804316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1.
    Ehses S; Raschke I; Mancuso G; Bernacchia A; Geimer S; Tondera D; Martinou JC; Westermann B; Rugarli EI; Langer T
    J Cell Biol; 2009 Dec; 187(7):1023-36. PubMed ID: 20038678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding SPG7 dominant optic atrophy phenotype: Infantile nystagmus and optic atrophy without spastic paraplegia.
    Seo Y; Lim HT; Lee BJ; Han J
    Am J Med Genet A; 2023 Feb; 191(2):582-585. PubMed ID: 36367250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OPA1 processing reconstituted in yeast depends on the subunit composition of the m-AAA protease in mitochondria.
    Duvezin-Caubet S; Koppen M; Wagener J; Zick M; Israel L; Bernacchia A; Jagasia R; Rugarli EI; Imhof A; Neupert W; Langer T; Reichert AS
    Mol Biol Cell; 2007 Sep; 18(9):3582-90. PubMed ID: 17615298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. m-AAA and i-AAA complexes coordinate to regulate OMA1, the stress-activated supervisor of mitochondrial dynamics.
    Consolato F; Maltecca F; Tulli S; Sambri I; Casari G
    J Cell Sci; 2018 Apr; 131(7):. PubMed ID: 29545505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory dysfunction by AFG3L2 deficiency causes decreased mitochondrial calcium uptake via organellar network fragmentation.
    Maltecca F; De Stefani D; Cassina L; Consolato F; Wasilewski M; Scorrano L; Rizzuto R; Casari G
    Hum Mol Genet; 2012 Sep; 21(17):3858-70. PubMed ID: 22678058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy.
    Klebe S; Depienne C; Gerber S; Challe G; Anheim M; Charles P; Fedirko E; Lejeune E; Cottineau J; Brusco A; Dollfus H; Chinnery PF; Mancini C; Ferrer X; Sole G; Destée A; Mayer JM; Fontaine B; de Seze J; Clanet M; Ollagnon E; Busson P; Cazeneuve C; Stevanin G; Kaplan J; Rozet JM; Brice A; Durr A
    Brain; 2012 Oct; 135(Pt 10):2980-93. PubMed ID: 23065789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.